Ong Ning

Dr. Ong Ning is a prominent researcher at the University of Texas MD Anderson Cancer Center, specializing in experimental cancer therapies. He recently led a groundbreaking study published in the Journal for ImmunoTherapy of Cancer, demonstrating the potential of artificial intelligence to analyze tumor biopsies and predict patients' responses to immunotherapy for rare cancers. His work emphasizes the integration of AI in cancer treatment, aiming to enhance decision-making in clinical settings.